Point-of-Care (POC) Coagulation Testing Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd

The Point-of-Care (POC) Coagulation Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Point-of-Care (POC) Coagulation Testing Market:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

According to The Business Research Company’s Point-of-Care (POC) Coagulation Testing Global Market Report 2024, The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.

The rising incidence of cardiovascular diseases is expected to propel the growth of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders of the heart and blood vessels, including conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is helpful in the treatment of cardiovascular diseases (CVDs) as it provides real-time information on coagulation status, enabling timely decision-making on coagulation interventions and reducing the risk of bleeding complications after cardiac surgery. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in the United States, heart disease claimed the lives of about 695,000 people in 2021, accounting for 1 in 5 fatalities. Further, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the point-of-care (POC) coagulation testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

The point-of-care (poc) coagulation testing market covered in this report is segmented –

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care

Major companies operating in the point-of-care (POC) coagulation testing market are focused on strategic collaborations to gain a competitive edge in the market. Strategic collaboration is a formal agreement between two or more parties to work together toward achieving specific, predetermined goals that are mutually beneficial. For instance, in October 2021, Trivitron Healthcare, an Indian-based medical devices company, collaborated with Diagon Ltd., a US-based manufacturer of IVD products, and Vanguard Diagnostics, an Indian-based manufacturer of diagnostic products, to launch Coagulation Analyzer products. It provides accurate and efficient coagulation testing, and the collaboration aims to improve patient diagnosis and management. The diverse range of analyzers caters to various healthcare settings, making coagulation testing more accessible.

The point-of-care (poc) coagulation testing market report table of contents includes:

1. Executive Summary
2. Point-of-Care (POC) Coagulation Testing Market    Characteristics
3. Point-of-Care (POC) Coagulation Testing Market    Trends And Strategies
4. Point-of-Care (POC) Coagulation Testing Market    – Macro Economic Scenario
5. Global  Point-of-Care (POC) Coagulation Testing Market    Size and Growth

.

.

.

32. Global  Point-of-Care (POC) Coagulation Testing Market    Competitive Benchmarking
33. Global  Point-of-Care (POC) Coagulation Testing Market    Competitive Dashboard
34. Key Mergers And Acquisitions In  Point-of-Care (POC) Coagulation Testing Market
35. Point-of-Care (POC) Coagulation Testing Market    Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• AT&T Corporation
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Hoffmann-La Roche Ltd

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model